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The innate immune system serves
as an initial line of defense against
microbial invaders and alerts the
adaptive immune system of the
impending assault. Because of its
critical role in initiating and
orchestrating a productive
immune response, it is imperative
to obtain a detailed understanding
of the microbial determinants that
are recognized by different
components and cells of the
innate immune system. Two
recent studies [1,2] have revealed
how one member of the innate
immune system, the natural killer
T (NKT) cell, is activated during
bacterial infections.
At first glance, NKT cells may
be easily mistaken as being part
of the adaptive immune system
(for recent reviews of NKT cell
biology, see [3,4]). Like
conventional T cells, NKT cells
express T-cell receptors (TCRs)
that are generated via somatic
DNA rearrangement. However,
closer scrutiny reveals that the
TCRs of most NKT cells are semi-
invariant, consisting of
Vα14–Jα18/Vβ8.2 chains in mouse
and homologous Vα24–Jα18/Vβ11
chains in human. Thus, the NKT
cell receptor resembles more
closely the conserved pattern-
recognition receptors of innate
immunity than the diverse
antigen-specific receptors of
adaptive immunity. 
In sharp contrast with
conventional T cells, which
recognize peptide antigens bound
to proteins encoded by the major
histocompatibility complex (MHC),
NKT cells recognize glycolipid
antigens presented by CD1d, a
non-polymorphic surface protein
related to classical MHC class I
molecules. Together with their
semi-invariant TCR, NKT cells
express a variety of surface
receptors (such as NK1.1 in
mouse) that are characteristic of
the natural killer cell lineage. With
regard to their functional
properties, NKT cells are activated
very early in an immune response
and are capable of activating a
variety of cell types, but lack
immunological memory. As such,
NKT cells appear to belong to the
innate rather than the adaptive
arm of the immune system.
While NKT cells have been
implicated in a wide variety of
immune responses [3,4], the
molecular determinants that
activate these cells have eluded
identification, until recently.
Because of their tendency to react
with autologous cells, it has been
generally assumed that NKT cells
born into a policing role, does
this mean that individuals start
out with equal potential to
assume such a role? How do
species that form other social
structures (for example, one-male
groups) achieve conflict control?
Might there be differences
between groups of the same
species in the extent of policing,
due to local differences in
consensual power politics? The
recent contribution by Flack et al.
[2] is a breakthrough that will
lead to other studies, which
means that the case of policing
by primates looks bound to
remain open for some time to
come.
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Innate Immunity: NKT Cells in the
Spotlight
Cells of the innate immune system provide a first line of defense
against microbial invaders. Recent studies have revealed how one
intriguing member of the innate immune system, the natural killer T
cell, is activated during bacterial infections.
Figure 1. NKT cell antigens.
Exogenous (α-GalCer and Sphingomonas glycolipids) and endogenous (iGb3) NKT cell
antigens. Sphingomonas glycolipids containing α-linked glucuronic or galacturonic acid
can activate NKT cells: glucuronic acid has the OH at the C-4’ position of the sugar in the
equatorial position and galacturonic acid has the OH in the axial position (see asterisk).
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can recognize both exogenous
and endogenous glycolipids. A
first breakthrough in the search
for NKT cell antigens was made a
few years ago by the finding that
all invariant NKT cells recognize
α-galactosylceramide (α-GalCer)
(Figure 1), a marine-sponge-
derived glycosphingolipid with a
multitude of immunomodulatory
activities that are being exploited
for therapeutic purposes [5–8].
However, because α-anomeric
glycosphingolipids are rare
among microorganisms and
absent from mammalian cells, α-
GalCer is not a physiological
antigen of NKT cells. Several
studies subsequently
demonstrated reactivity of NKT
cells to certain cellular [9,10],
tumor-derived [11] and microbial
[12,13] lipids, but these reagents
were recognized by only small
subsets of NKT cells. 
A second breakthrough was
made recently by the finding that
an endogenous, lysosomal
glycosphingolipid,
isoglobotrihexosylceramide (iGb3)
(Figure 1), was required for the
intrathymic development of NKT
cells and was capable of
activating NKT cells, albeit less
potently than α-GalCer [14]. How
iGb3 contributed to the activation
of NKT cells in health and disease
was unclear, however. The new
papers by Kinjo et al. [1] and
Mattner et al. [2] represent yet
another breakthrough in the
search for NKT cell antigens, by
demonstrating that bacterially
derived glycosylceramides can
activate all invariant NKT cells.
The paper by Mattner et al. [2]
further demonstrates a critical role
of iGb3 in the activation of NKT
cells during infections with
bacteria that contain
lipopolysaccharide (LPS) in their
cell wall.
NKT cells become activated
during a variety of infections and
contribute to protective host
immune responses in some
cases [15]. In the case of
infection with Salmonella
typhimurium, a Gram-negative
bacterium that contains LPS in its
cell wall, Brigl et al. [16]
previously demonstrated that
NKT cells become activated
independent of cognate microbial
antigens. Instead, NKT cells
appeared to be activated
secondarily to the activation of
dendritic cells (DCs). DCs can
sense microbial products such as
LPS by engagement with Toll-like
receptors (TLRs), resulting in the
induction of a variety of co-
stimulatory molecules and
cytokines, including interleukin-
12 (IL-12) [17], a potent stimulator
of interferon-γ (IFN-γ) production
by NKT cells [18]. Because LPS
or IL-12 were able to replace
Salmonella bacteria in the NKT
cell stimulation assay [16], it was
clear that microbial NKT cell
antigens were not involved. 
Surprisingly, however, NKT cell
activation required CD1d
expression by DCs, suggesting a
model of NKT cell activation by
LPS-containing bacteria involving
weak responses to self-
glycolipids that are amplified by
IL-12, produced by DCs. The
paper by Mattner et al. [2] now
demonstrates that Salmonella-
treated DCs from mice lacking β-
hexosaminidase, an enzyme
required for the generation of
iGb3 in lysosomes, were unable to
stimulate NKT cells. In addition,
the lectin IB4, which specifically
recognizes iGb3, blocked the
response of NKT cells to
Salmonella-pulsed wild-type DCs.
Hence, these studies identified
iGb3 as the critical endogenous
glycolipid for NKT cell activation
in response to LPS-containing
bacteria.
What about LPS-negative
bacteria? The new papers
demonstrate that infection with
Sphingomonas and Ehrlichia spp.,
Gram-negative bacteria that lack
LPS, also results in NKT cell
activation [1,2]. However, unlike
the response to LPS-containing
bacteria, this recognition was
independent of β-hexosaminidase
expression by antigen-presenting
cells and resisted blockade by
IB4, indicating that reactivity with
iGb3 was not required.
Nevertheless, NKT cell activation
was dependent on CD1d
expression by DCs, suggesting
that NKT cells recognized specific
microbial antigens. Because
glycolipids from the cell wall of
Sphingomonas have been
characterized at the molecular
level, the investigators were able
to identify two related
glycosylceramides, α-
glucuronosylceramide and α-
galacturonosylceramide (Figure 1),
that stimulated NKT cells.
These novel findings reveal two
alternative mechanisms of
microbial recognition by NKT cells
(Figure 2). For Gram-negative
bacteria containing LPS,
recognition of microbial products
by TLRs on DCs results in IL-12
production, which amplifies low-
affinity interactions of the NKT cell
receptor with iGb3–CD1d
complexes (Figure 2A). It remains
to be determined, however,
Current Biology Vol 15 No 11
R430
Figure 2. Two alternative strategies for NKT cell activation by microbes. 
(A) Microbes containing TLR ligands such as LPS can activate NKT cells by inducing
IL-12 production by DCs, which amplifies the weak responses of the invariant NKT cell
receptor to iGb3–CD1d complexes. (B) Alternatively, microbes may activate NKT cells
directly via glycosphingolipids that bind CD1d on the DCs and interact with the invari-
ant NKT cell receptor, without the need for endogenous NKT cell antigens such as iGb3. 
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whether NKT cell activation in this
manner involves alterations in
CD1d or iGb3 expression by the
antigen-presenting cells.
Alternatively, for certain Gram-
negative bacteria that lack LPS,
NKT cells may be activated by
specific microbial
glycosphingolipids, without the
need for endogenous NKT cell
antigens such as iGb3 (Figure 2B).
What are the implications of
these findings for host immunity
against bacterial infections? For
LPS-containing bacteria, NKT
cells represent only one of several
cell types activated downstream
of DCs. Therefore, NKT cell
activation may be redundant with
other innate immune mechanisms,
as exemplified by the finding that
wild-type and NKT-cell-deficient
mice have similar susceptibility to
Salmonella infection [19].
Nevertheless, this mechanism of
NKT cell activation likely plays an
important role in the immune
response to other LPS-containing
bacteria. Direct recognition of
microbial glycolipids by NKT cells
is probably critically important
because NKT-cell-deficient mice
were impaired in clearing
Sphingomonas and Ehrlichia
bacteria in low-dose infection
models [1,2]. However, high-dose
infection of wild-type animals with
Sphingomonas resulted in a
sepsis-like syndrome and death,
whereas most NKT-cell-deficient
mice survived [2]. The latter
findings may provide an
explanation for the septic shock
that has been observed in
immunocompromised humans
infected with Sphingomonas [20].
Thus, exposure to microbial NKT
cell antigens can induce both
beneficial and adverse immune
responses, depending on the
extent of NKT cell activation.
The implications of the new
studies extend well beyond
microbial immune defense
mechanisms. First, in addition to
its role in infections, iGb3 may
contribute to the activation of NKT
cells during a variety of other
diseases, including tumorigenesis,
autoimmunity and allergies.
Second, microbial NKT cell
antigens could impact the
initiation and progression of
autoimmune and allergic
diseases. Finally, considering the
promising preclinical studies with
α-GalCer as a therapy for a variety
of diseases [7,8], it is likely that
iGb3 and the newly identified
microbial NKT cell antigens will
prove useful for the development
of NKT-cell-based vaccine
adjuvants and therapeutics.
References
1. Kinjo, Y., Wu, D.Y., Kim, G., Xing, G.-W.,
Poles, M.A., Ho, D.D., Tsuji, M.,
Kawahara, K., Wong, C.-H., and
Kronenberg, M. (2005). Recognition of
bacterial glycosphingolipids by natural
killer T cells. Nature 434, 520–525.
2. Mattner, J., DeBord, K.L., Ismail, N.,
Goff, R.D., Cantu, C.I., Zhou, D., Saint-
Mezard, P., Wang, V., Gao, Y., Yin, N., et
al. (2005). Exogenous and endogenous
glycolipid antigens activate NKT cells
during microbial infections. Nature 434,
525–529.
3. Brigl, M., and Brenner, M.B. (2004). CD1:
antigen presentation and T cell function.
Annu. Rev. Immunol. 22, 817–890.
4. Godfrey, D.I., and Kronenberg, M. (2004).
Going both ways: immune regulation via
CD1d-dependent NKT cells. J. Clin.
Invest. 114, 1379–1388.
5. Kobayashi, E., Motoki, K., Uchida, T.,
Fukushima, H., and Koezuka, Y. (1995).
KRN7000, a novel immunomodulator,
and its antitumor activities. Oncol. Res.
7, 529–534.
6. Kawano, T., Cui, J., Koezuka, Y., Toura,
I., Kaneko, Y., Motoki, K., Ueno, H.,
Nakagawa, R., Sato, H., Kondo, E., et al.
(1997). CD1d-restricted and TCR-
mediated activation of Vα14 NKT cells by
glycosylceramides. Science 278,
1626–1629.
7. Wilson, M.T., Singh, A.K., and Van Kaer,
L. (2002). Immunotherapy with ligands of
natural killer T cells. Trends Mol. Med. 8,
225–231.
8. Van Kaer, L. (2005). α-
Galactosylceramide therapy for
autoimmune diseases: prospects and
obstacles. Nat. Rev. Immunol. 5, 31–42.
9. Gumperz, J.E., Roy, C., Makowska, A.,
Lum, D., Sugita, M., Podrebarac, T.,
Koezuka, Y., Porcelli, S.A., Cardell, S.,
Brenner, M.B., et al. (2000). Murine
CD1d-restricted T cell recognition of
cellular lipids. Immunity 12, 211–221.
10. Stanic, A.K., De Silva, A.D., Park, J.J.,
Sriram, V., Ichikawa, S., Hirabyashi, Y.,
Hayakawa, K., Van Kaer, L., Brutkiewicz,
R.R., and Joyce, S. (2003). Defective
presentation of the CD1d1-restricted
natural Vα14Jα18 NKT lymphocyte
antigen caused by β-D-glucosylceramide
synthase deficiency. Proc. Natl. Acad.
Sci. USA 100, 1849–1854.
11. Wu, D.Y., Segal, N.H., Sidobre, S.,
Kronenberg, M., and Chapman, P.B.
(2003). Cross-presentation of
disialoganglioside GD3 to natural killer T
cells. J. Exp. Med. 198, 173–181.
12. Fischer, K., Scotet, E., Niemeyer, M.,
Koebernick, H., Zerrahn, J., Maillet, S.,
Hurwitz, R., Kursar, M., Bonneville, M.,
Kaufmann, S.H.E., et al. (2004).
Mycobacterial phosphatidylinositol
mannoside is a natural antigen for CD1d-
restricted T cells. Proc. Natl. Acad. Sci.
USA 101, 10685–10690.
13. Amprey, J.L., Im, J.S., Turco, S.J.,
Murray, H.W., Illarionov, P.A., Besra,
G.S., Porcelli, S.A., and Spath, G.F.
(2004). A subset of liver NK T cells is
activated during Leishmania donovani
infection by CD1d-bound
lipophosphoglycan. J. Exp. Med. 200,
895–904.
14. Zhou, D., Mattner, J., Cantu, C.,
Schrantz, N., Yin, N., Gao, Y., Sagiv, Y.,
Hudspeth, K., Wu, Y., Yamashita, T., et
al. (2004). Lysosomal glycophingolipid
recognition by NKT cells. Science 306,
1786–1789.
15. Skold, M., and Behar, S.M. (2003). Role
of CD1d-restricted NKT cells in microbial
immunity. Infect. Immun. 71, 5447–5455.
16. Brigl, M., Bry, L., Kent, S.C., Gumperz,
J.E., and Brenner, M.B. (2003).
Mechanism of CD1d-restricted natural
killer T cell activation during microbial
infection. Nat. Immunol. 4, 1230–1237.
17. Akira, S., and Takeda, K. (2004). Toll-like
receptor signalling. Nat. Rev. Immunol. 4,
499–511.
18. Cui, J., Shin, T., Kawano, T., Sato, H.,
Kondo, E., Toura, I., Kaneko, Y., Koseki,
H., Kanno, M., and Taniguchi, M. (1997).
Requirement for Vα14 NKT cells in IL-12-
mediated rejection of tumors. Science
278, 1623–1626.
19. Ishigami, M., Nishimura, H., Naiki, Y.,
Yoshioka, K., Kawano, T., Tanaka, Y.,
Taniguchi, M., Kakumu, S., and Yoshikai,
Y. (1999). The roles of intrahepatic Vα14+
NK1.1+ T cells for liver injury induced by
Salmonella infection in mice. Hepatology
29, 1799–1808.
20. Perola, O., Nousiainen, T., Suomalainen,
S., Aukee, S., Karkkainen, U.M.,
Kauppinen, J., Ojanen, T., and Katila,
M.L. (2002). Recurrent Sphingomonas
paucimobilis-bacteraemia associated
with a multi-bacterial water-borne
epidemic among neutropenic patients. J.
Hosp. Infect. 50, 196–201.
Department of Microbiology and
Immunology, 1161 21st Avenue South,
Vanderbilt University School of
Medicine, Nashville, Tennessee 37232,
USA.
E-mail: luc.van.kaer@vanderbilt.edu
DOI: 10.1016/j.cub.2005.05.032
Dispatch    
R431
